|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
26546614 |
14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.
Mutations in leucine-r |
1.6 KB |
2020-01-21 |
|
13 |
|
109 |
2021-01-27
|
| PubMed |
26363496 |
(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of gene |
1.28 KB |
2020-01-21 |
|
10 |
|
74 |
2021-01-27
|
| PubMed |
26343330 |
Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression.
We describe a pr |
1.66 KB |
2020-01-22 |
|
10 |
|
214 |
2021-01-27
|
| PubMed |
26333255 |
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and |
2.09 KB |
2020-01-28 |
|
12 |
|
145 |
2021-01-27
|
| PubMed |
26295712 |
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation.
T |
2.48 KB |
2016-01-24 |
|
9 |
|
208 |
2021-01-27
|
| PubMed |
26282470 |
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant |
2.01 KB |
2020-01-21 |
|
9 |
|
118 |
2021-01-27
|
| PubMed |
26269629 |
The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippoc |
2.35 KB |
2020-01-29 |
|
10 |
|
127 |
2021-01-27
|
| PubMed |
26255059 |
Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in s |
1.9 KB |
2020-01-22 |
|
8 |
|
150 |
2021-01-27
|
| PubMed |
26253900 |
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigros |
1.59 KB |
2020-01-21 |
|
8 |
|
114 |
2021-01-27
|
| PubMed |
26251043 |
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduc |
1.87 KB |
2020-01-21 |
|
9 |
|
100 |
2021-01-27
|
